SARS-CoV-2 Testing Before International Airline Travel, December 2020 to May 2021.
Mayo Clin Proc
; 96(11): 2856-2860, 2021 11.
Article
in English
| MEDLINE | ID: covidwho-1492385
ABSTRACT
Although there have been several case reports and simulation models of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission associated with air travel, there are limited data to guide testing strategy to minimize the risk of SARS-CoV-2 exposure and transmission onboard commercial aircraft. Among 9853 passengers with a negative SARS-CoV-2 polymerase chain reaction test performed within 72 hours of departure from December 2020 through May 2021, five (0.05%) passengers with active SARS-CoV-2 infection were identified with rapid antigen tests and confirmed with rapid molecular test performed before and after an international flight from the United States to Italy. This translates to a case detection rate of 1 per 1970 travelers during a time of high prevalence of active infection in the United States. A negative molecular test for SARS-CoV-2 within 72 hours of international airline departure results in a low probability of active infection identified on antigen testing during commercial airline flight.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Air Travel
/
COVID-19 Testing
/
SARS-CoV-2
/
COVID-19
Type of study:
Diagnostic study
/
Experimental Studies
/
Observational study
/
Prognostic study
Limits:
Humans
Country/Region as subject:
North America
/
Europa
Language:
English
Journal:
Mayo Clin Proc
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS